Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$34.44 - $43.75 $172,200 - $218,750
-5,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$27.12 - $45.97 $135,600 - $229,850
5,000 New
5,000 $305,000

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $28.5M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Symmetry Peak Management LLC Portfolio

Follow Symmetry Peak Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Symmetry Peak Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Symmetry Peak Management LLC with notifications on news.